
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Applying endocrine strategies in HER2‑positive disease
Hamilton highlights PATINA findings and the role of endocrine plus CDK therapy in ER+/HER2+ maintenance settings.
Play episode from 54:26
Transcript


